Emerging Therapeutic Applications for Fumarates

Ayla Hoogendoorn, Thomas D. Avery, Jiahe Li, Christina Bursill, Andrew Abell, Peter M. Grace

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

Fumarates are successfully used for the treatment of psoriasis and multiple sclerosis. Their antioxidative, immunomodulatory, and neuroprotective properties make fumarates attractive therapeutic candidates for other pathologies. The exact working mechanisms of fumarates are, however, not fully understood. Further elucidation of the mechanisms is required if these drugs are to be successfully repurposed for other diseases. Towards this, administration route, dosage, and treatment timing, frequency, and duration are important parameters to consider and optimize with clinical paradigms in mind. Here, we summarize the rapidly expanding literature on the pharmacokinetics and pharmacodynamics of fumarates, including a discussion on two recently FDA-approved fumarates VumerityTM and BafiertamTM. We review emerging applications of fumarates, focusing on neurological and cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)239-254
Number of pages16
JournalTrends in Pharmacological Sciences
Volume42
Issue number4
DOIs
StatePublished - Apr 2021

Keywords

  • atherosclerosis
  • fumarates
  • ischemia-reperfusion injury
  • neurodegenerative disease
  • neuropathic pain

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint

Dive into the research topics of 'Emerging Therapeutic Applications for Fumarates'. Together they form a unique fingerprint.

Cite this